◆ SpookStack

Mori ID 4 V31551 ISESS2 151553 (51759 ISn760 ISEP6L 151762 151763 US1764 151765 131766 151767 151768 IS1769 Is170 IS1T71 S172 151772 Pub Date OLO9ST OAL T9S7 OAT 9S7 OS 21989 05/01/1959 O54 V19s9 OS] 0959 O09 L959 LEB 1959 TIS 959 1051989 1120/1959 TROL 9S9 TE LO 9S9 T2/TF9S9 12241959 O125/1G60 D210 ‘ages Document Title (ESTIMATED PUB DATE) (UNTITLED) RE DESCRIPTION OF DRUGS AND ITS EFFECT ON PEOPLE ANNUAL PROGRESS REPORT PREPARED BY HARRIS ISBELL - | JANUARY 1956-70 31 DECMEBER 1956 (ESTIMATED PUB DATE) ADDICTION LIABILITIES OF SYNTHETIC SUBSTITUTES FOR CODEINE D-DIHYDRO-LYSERGIC ACID DIETHYLA MIDE (V-A-24) (ESTIMATED PUB DATE) 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE TARTRATE (UMIL-491, v- AAS). ELYMOCLAVINE (43-41, CROSS TOLERANCE BETWEEN LSD-25 AND PSILOCY BIN. LETTER TO NATIONAL INSTITUTE OF MENTAL HEALTH RE 1-{BETA-DIETHYLAMINOETHYL)-2-¢P- ETHOXY BBENZYL)-5-NITROBENZIMIDAZOLE METHANE SULFONATE (FA-20684, NIH-7607, ARC 1. G-2) WITHOUT ENCLOSURES t, PROGRESS REPORT ABSTRACT, TASK NO. NR 101-149, CONTRACT NAON R- 14-60, 2. REQUEST FOR RENEWAL OF PROJECT, JULY 1960 THROUGH JLINE (961, 3. MEMORANDUM TO MR. LEONARD M, LIBBER, HEAD, PHYSIOLOGY BRANCH, ONR WITHOUT ENCLOSURES |, PROGRESS REPORT ABSTRACT, TASK NO. NR 101-149, CONTRACT NAGNR. 14-60, 2. REQUEST FOR RENEWAL OF PROJECT, JULY 1960 THROUGH JUNE 1961 WITHOUT ENCLOSURE {ESTIMATED PUB DATE) THE ADDICTION LIABILITIES OF SYNTHETIC SUBSTITUTES FOR CODEINE WITH ENCLOSED PROJECT DESCRIPTION AND ATTACHMENT LETTER FROM HARRIS ISBELL TO WORLD HEALTH ORGANIZATION RE HIS ADDRESS AND TELEPHONE NUMBER (ESTIMATED PUB DATE} LETTER TO DR. HARRIS ISBELL RE SETTING ESTABLISHING A TELEPHONE CONVERSATION IN DECEMBER WITH (DELETED) OW A MATTER OF MUTUAL INTEREST (ESTIMATED PUB DATE) LETTER TO OR. HARRIS ISBELL FROM RAY RE TRANSMITTAL OF PACKAGE AND REQUEST FOR INFORMATION ON THE BENZIMIDAZOLE DERIVATIVE LETTER TO RAY FROM ISBELL HARRIS RE TEMPORARY MAILING ADDRESS LETTER TO NATIONAL INSTITUTE OF MENTAL HEALTH RE PRESENTATION OF PAPER TITLED “USE OF A BENZIMIDAZOLE DERIVATIVE WITH POTENT MORPHINE-LIKE PROPERTIES ORALLY ASA PRESUMPTION REINFORCER IN CONDITIONING OF DRUG-SEEKING BEHAVIOR IN RATS" WITHOUT ENCLOSURE LETTER TO DR. RUDOLF @RICHER (SANOZ PHARMA CEUTICALS} FROM ABRAHAM WIKLER RE PSILOCYBIN AND LSD-25 WITH ENCLOSURES LETTER TO NATIONAL INSTITUTE OF MENTAL HEALTH FROM ABRAHAM WIKLER RE LETTER & STUDY RESULTS SENT TO DR, R. BIRCHER (SANDOZ, INCORPORATED) RE PSILOCYBIN AND LSD- ii